Skip to main content

Table 9 Characteristics and outcome of feline patients treated chemotherapy alone for chemoresistant cancers

From: Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors

PATIENT AGE TUMOR PREV.
TREATMENT
THERAPY OUTCOME
(MONTHS)
DSH 10 BREAST
CARCINOMA
DOXORUBICIN
CARBOPLATIN
CARBOPLATIN PD 1
DSH 12 FSA CARBOPLATIN CARBOPLATIN PR 2
DSH 10 ORAL SCC MITOXANTRONE
CARBOPLATIN
MITOXANTRONE PD 1
DSH 12 ORAL FSA DOXORUBICIN
CARBOPLATIN
CARBOPLATIN PD 1
DSH 12 LSA MADISON
MOPP
MOPP PR 2
DSH 7 FSA SURGERY,
DOXORUBICIN
CARBOPLATIN
CARBOPLATIN PD 1
NORVEGIAN 7 LSA MADISON
MOPP
MOPP PD 2
  1. Abbreviations: DSH: domestic short hair; FSA: fibrosarcoma; LSA: lymphosarcoma; MOPP: mechlorethamine, oncovin (vincristine), prednisone, procarbazine; SCC: squamous cell carcinoma. +: still alive.
  2. Drugs schedule: doxorubicin 30 mg/m2 every 21 days (pending hematological, cardiac and renal evaluation) up to 6 doses, carboplatin 210 mg/m2 every 21 days, mitoxantrone 6 mg/m2 every 21 days. For Madison and MOPP protocols see table 4 and 5.